AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS
Clinical trial NCT00396968 · WITHDRAWN
Trial details
- NCT number
- NCT00396968
- Sponsor
- Genzyme, a Sanofi Company
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.